General Updates

Date: September 21, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Subject.: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 [‘SEBI (LODR) Regulations]- Clarification on movement in volume Dear Sir/Madam, This has reference to your letter dated September 21, 2026 seeking clarification on movement in volume. We would like to inform you that the Company is in compliance with SEBI (LODR) Regulations and has been promptly informing the Stock Exchanges on all events and information, which have a bearing on operation or performance of the Company. There is no undisclosed / price sensitive information or any impending announcement / corporate action which needs to be informed to the exchange at this point of time. Further, we would like to assure you that Company will, as required under SEBI (LODR) Regulations 2015, continue to promptly inform the exchanges of all material events / information / actions. We hope the above clarifies and request you to kindly take the same on your records please. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary and Compliance Officer ICSI Membership No.: A34516 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263